Leo Wealth LLC’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
Other funds holding BMY
Leo Wealth LLC's BMY Position: Q3 2026 in Review
Leo Wealth LLC opened a new position in Bristol-Myers Squibb (BMY) in Q3 2026: 39,189 shares worth $2.45M. The stake represents 0.52% of the portfolio and ranks #43 among its holdings. This is a return to the name: Leo Wealth LLC previously reported a position in BMY as recently as Q1 2026.
Leo Wealth LLC first reported a position in BMY in Q4 2023 and has held it in 11 quarters since. The position peaked at $4M in Q1 2026. 1,520 funds tracked by Wall St. Rank hold BMY as of Q3 2026.
- Leo Wealth LLC held 39,189 shares of Bristol-Myers Squibb worth $2.45M as of Q3 2026.
- Bristol-Myers Squibb was a new Leo Wealth LLC position in Q3 2026.
- Bristol-Myers Squibb made up 0.52% of Leo Wealth LLC's portfolio in Q3 2026, its #43 holding.
- Leo Wealth LLC first reported a position in Bristol-Myers Squibb in Q4 2023 and has held it in 11 quarters since.
- Leo Wealth LLC's Bristol-Myers Squibb position peaked at $4M in Q1 2026.
- 1,520 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q3 2026.
Based on Leo Wealth LLC's 13F filing for Q3 2026, filed 26 Oct 2026.